| [1] |
San Juan Galán J, Poliquin V, Gerstein AC. 2023. Insights and advances in recurrent vulvovaginal candidiasis. |
| [2] |
Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. 2020. Vulvovaginal candidiasis: a current understanding and burning questions. |
| [3] |
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, et al. 2021. Sexually transmitted infections treatment guidelines, 2021. |
| [4] |
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, et al. 2016. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. |
| [5] |
Intra J, Sala MR, Brambilla P, Carcione D, Leoni V. 2022. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: a retrospective study over a 20 year-period. |
| [6] |
Donders G, Sziller IO, Paavonen J, Hay P, de Seta F, et al. 2022. Management of recurrent vulvovaginal candidosis: narrative review of the literature and European expert panel opinion. |
| [7] |
Pan Y, Sun Y, Chen L, Cheng Y, Jin P, et al. 2023. Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium. |
| [8] |
Fleiss JL, Levin B, Paik MC. 2003. Statistical Methods for Rates and Proportions. Hoboken, N.J.: John Wiley & Sons Inc. pp. 760 doi: 10.1002/0471445428 |
| [9] |
Okungbowa FI, Isikhuemhen OS, Dede AP. 2003. The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian cities. Revista Iberoamericana de Micologia 20(2):60−63 |
| [10] |
Enweani IB, Gugnani HC, Okobia R, Ojo SB. 2001. Effect of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State, Nigeria. Revista Iberoamericana de Micologia 18(4):171−173 |
| [11] |
de Souza CM, Dos Santos MM, Furlaneto-Maia L, Furlaneto MC. 2023. Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: what do we know? |
| [12] |
Ogba OM, Chidinma BD, Inah IO, Ogba RO, Akpan NG, et al. 2024. Catheter associated Candiduria among in-patients accessing care in a Tertiary Health Institution in Calabar, Nigeria. |
| [13] |
Coignard C, Hurst SF, Benjamin LE, Brandt ME, Warnock DW, et al. 2004. Resolution of discrepant results for Candida species identification by using DNA probes. |
| [14] |
Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC. 2010. Candida albicans forms biofilms on the vaginal mucosa. |
| [15] |
Espinel-Ingroff A. 2022. Commercial methods for antifungal susceptibility testing of yeasts: strengths and limitations as predictors of resistance. |
| [16] |
Clinical and Laboratory Standards Institute (CLSI). 2022. Performance standards for antifungal susceptibility testing of yeasts (3rd ed., CLSI supplement M27M44S) |
| [17] |
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, et al. 2021. Guideline: vulvovaginal candidosis (AWMF 015/072, level S2k). |
| [18] |
Sherrard J, Donders G, White D, Jensen JS. 2011. European (IUSTI/WHO) guideline on the management of vaginal discharge. |
| [19] |
Gaziano R, Sabbatini S, Monari C. 2023. The interplay between Candida albicans, vaginal mucosa, host immunity and resident microbiota in health and disease: an overview and future perspectives. |
| [20] |
Cavalheiro M, Teixeira MC. 2018. Candida biofilms: threats, challenges, and promising strategies. |
| [21] |
Bitew A, Abebaw Y. 2018. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. |
| [22] |
Bhattacharya S, Sae-Tia S, Fries BC. 2020. Candidiasis and mechanisms of antifungal resistance. |
| [23] |
Cornely OA, Sprute R, Bassetti M, Chen SCA, Groll AH, et al. 2025. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. |
| [24] |
Donders GGG, Bellen G, Ruban K, Van Bulck B. 2018. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida. |
| [25] |
Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. 2019. Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997−2016. |